H.R. 5343 (119th)Legislative Design
Ensuring Patient Access to Critical Breakthrough Products Act
Health|Congressional oversightDrug safety, medical device, and laboratory regulation
Sponsor
Cosponsors
Support
Bipartisan
Introduced
Sep 15, 2025
Discussions
Committee
Current stageCommittee
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.
Introduced
Committee
Floor
President
Law
Legislative design
How complete and executable the bill text feels.
iThis page explains why each dimension scored the way it did, and which parts of implementation are explicit versus left to future interpretation.
No legislative design analysis yet for this bill.